Globus Medical (GMED) PT Raised to $65 at Needham & Company

August 2, 2018 8:15 AM

Needham & Company raised its price target on Globus Medical (NYSE: GMED) to $65.00 (from $58.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found